Based on recent evaluations by the National Cancer Center and Fudan Hospital Rankings (as of 2025), the following hospitals are leaders in cancer diagnosis and treatment:
1. Cancer Hospital, Chinese Academy of Medical Sciences (Beijing)
Strengths: National Cancer Center; specializes in lung, esophageal, and gynecologic cancers. Equipped with proton therapy and Da Vinci surgical systems.
Experts: He Jie (Thoracic Surgery), Sun Yan (Medical Oncology), Wu Lingying (Gynecologic Oncology)
2. Sun Yat-sen University Cancer Center (Guangzhou)
Strengths: World leader in nasopharyngeal carcinoma; excels in liver and colorectal cancer precision therapy and immunotherapy combinations.
Experts: Xu Ruihua (GI Oncology), Ma Jun (Radiation Therapy)
3. Fudan University Shanghai Cancer Center
Strengths: Creator of "Fudan subtyping" for breast cancer; strong in pancreatic and head & neck cancer; home to largest proton and heavy ion center.
Experts: Shao Zhimin (Breast Cancer), Yu Xianjun (Pancreatic Cancer)
4. Peking University Cancer Hospital (Beijing)
Strengths: Minimally invasive surgery for gastric and colorectal cancer; strong experience in melanoma and lymphoma immunotherapy.
Experts: Ji Jiafu (Gastric Cancer), Shen Lin (Translational Oncology)
5. Fuda Cancer Hospital (Guangzhou)
Strengths: Specializes in integrative medicine, immunotherapy, and minimally invasive techniques.
Experts: Niu Lizhi (Cryoablation)
Top Hospitals by Cancer Type and Technology
Lung Cancer
· Cancer Hospital, Chinese Academy of Medical Sciences: PD-1 + proton therapy improved 5-year survival by 30%.
· West China Hospital of Sichuan University: AI resistance prediction + Da Vinci robotic surgery with 0.1mm precision.
Nasopharyngeal Carcinoma
· Sun Yat-sen University Cancer Center: Protocol by Ma Jun adopted in global guidelines; 5-year survival: 84%.
Breast Cancer
· Fuda Cancer Hospital: Advanced breast reconstruction techniques, leading in Asia.
Digestive Tract Cancers (Gastric/Colorectal)
· Peking University Cancer Hospital: Neoadjuvant therapy from Ji Jiafu's team; 5-year survival over 60%.
· Zhejiang University First Affiliated Hospital: BACE increases local drug concentration by 20 times.